Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YELLOW: Aggressive Lipid Lowering Therapy
NCT01567826Phase 4Completed
- Start
- May 2010
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in coronary artery disease (CAD). Started May 2010; status: completed.
02
Drugs
rosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01567826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01567826.